Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 10.20
-0.55 (-5.12%)
At close: Mar 9, 2026
Telix Pharmaceuticals Ratios and Metrics
Market cap in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,456 | 3,794 | 8,238 | 3,263 | 2,300 | 2,209 | Upgrade
|
| Market Cap Growth | -66.18% | -53.94% | 152.44% | 41.89% | 4.10% | 108.44% | Upgrade
|
| Enterprise Value | 3,943 | 4,116 | 8,141 | 3,145 | 2,180 | 2,161 | Upgrade
|
| Last Close Price | 10.20 | 11.20 | 24.61 | 10.08 | 7.27 | 7.75 | Upgrade
|
| PE Ratio | - | - | 151.34 | 528.32 | - | - | Upgrade
|
| Forward PE | - | 282.12 | 87.27 | 32.83 | - | - | Upgrade
|
| PS Ratio | 2.87 | 3.15 | 9.87 | 6.68 | 14.37 | 290.85 | Upgrade
|
| PB Ratio | 5.55 | 6.09 | 14.44 | 21.66 | 28.75 | 1023.78 | Upgrade
|
| P/TBV Ratio | - | - | 53.62 | 80.58 | 109.40 | - | Upgrade
|
| P/FCF Ratio | - | - | 277.46 | 279.08 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 185.44 | 155.76 | - | - | Upgrade
|
| EV/Sales Ratio | 3.27 | 3.42 | 9.75 | 6.43 | 13.62 | 284.54 | Upgrade
|
| EV/EBITDA Ratio | 65.37 | 84.58 | 84.48 | 56.13 | - | - | Upgrade
|
| EV/EBIT Ratio | 136.37 | 142.35 | 90.15 | 61.25 | - | - | Upgrade
|
| EV/FCF Ratio | -61.19 | - | 274.21 | 268.94 | - | - | Upgrade
|
| Debt / Equity Ratio | 1.13 | 1.13 | 1.02 | 0.12 | 0.13 | 1.18 | Upgrade
|
| Debt / EBITDA Ratio | 11.61 | 11.61 | 5.89 | 0.31 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | 19.60 | 1.54 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.78 | 0.78 | -0.23 | -0.70 | -1.32 | -9.03 | Upgrade
|
| Net Debt / EBITDA Ratio | 10.02 | 10.02 | -1.34 | -1.89 | 1.52 | 0.25 | Upgrade
|
| Net Debt / FCF Ratio | -7.57 | -7.57 | -4.34 | -9.04 | 1.49 | 0.32 | Upgrade
|
| Asset Turnover | 0.76 | 0.76 | 0.85 | 1.48 | 0.88 | 0.06 | Upgrade
|
| Inventory Turnover | 13.90 | 13.90 | 10.84 | 14.01 | 10.92 | 1.25 | Upgrade
|
| Quick Ratio | 1.21 | 1.21 | 2.63 | 1.20 | 1.90 | 1.13 | Upgrade
|
| Current Ratio | 1.43 | 1.43 | 2.78 | 1.43 | 2.03 | 1.25 | Upgrade
|
| Return on Equity (ROE) | -1.85% | -1.85% | 14.79% | 5.36% | -253.34% | -198.36% | Upgrade
|
| Return on Assets (ROA) | 1.15% | 1.15% | 5.74% | 9.69% | -25.37% | -37.95% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.60% | 3.81% | 32.69% | 537.03% | - | - | Upgrade
|
| Return on Capital Employed (ROCE) | 2.10% | 2.10% | 7.60% | 21.10% | -43.60% | -113.10% | Upgrade
|
| Earnings Yield | -0.31% | -0.28% | 0.66% | 0.19% | -4.53% | -3.64% | Upgrade
|
| FCF Yield | -1.86% | -1.70% | 0.36% | 0.36% | -3.09% | -2.75% | Upgrade
|
| Buyback Yield / Dilution | 2.12% | 2.12% | -6.64% | -4.21% | -10.08% | -9.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.